Physical therapy assessment tools to evaluate disease progression and phenotype variability in Golden Retriever muscular dystrophy

Research in Veterinary Science

Volumn 91, Issue 2, 2011, Pages 188-193

  Gaiad, T P ^a   Silva, M B ^a   Silva, G C A ^b   Caromano, F A ^a   Miglino, M A ^a   Ambrosio C E ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b University Center Italo Brasileiro   (Brazil)

Author keywords

Canine model; Duchenne muscular dystrophy; Limb circumference; Phenotypic variability; Physical features; Range of motion

Indexed keywords

CREATINE KINASE;

ANIMAL EXPERIMENT; ANIMAL MUSCULAR DYSTROPHY; ANTHROPOMETRIC PARAMETERS; ARTICLE; BODY WEIGHT; CLINICAL ASSESSMENT TOOL; CONTROLLED STUDY; CREATINE KINASE BLOOD LEVEL; DISEASE COURSE; DOG; FEMALE; LIMB CIRCUMFERENCE; MALE; NONHUMAN; PHENOTYPIC VARIATION; PHYSIOTHERAPY; RANGE OF MOTION; THERAPY EFFECT; THORAX CIRCUMFERENCE;

ANIMALS; BRAZIL; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; DOG DISEASES; DOGS; FEMALE; HUMANS; MALE; MUSCLE, SKELETAL; MUSCULAR DYSTROPHY, ANIMAL; MUSCULAR DYSTROPHY, DUCHENNE; PATHOLOGY, VETERINARY; PHENOTYPE; PHYSICAL EXAMINATION; PHYSICAL THERAPY MODALITIES;

CANIS FAMILIARIS;

EID: 80052087602     PISSN: 00345288     EISSN: 15322661     Source Type: Journal    
DOI: 10.1016/j.rvsc.2011.01.007     Document Type: Article

References (28)

1. Alves F.R., Feitosa M.L.T., Gatti A., Fadel L., Unruh S.M., Ambrósio C.E., Sterman F.A., Pinto A.C.B.C.F., Miglino M.A. Imagem radiográfica da cavidade torácica de cães Golden Retriever acometidos pela distrofia muscular. Pesquisa Veterinaria Brasileira 2009, 29:99-104.
2. Ambrósio C.E., Valadares M., Zucconi E., Cabral R., Pearson P.L., Gaiad T.P., Canovas M., Vainzof M., Miglino M.A., Zatz M. Ringo, a Golden Retriever Muscular Dystrophy (GRMD) dog with absent dystrophin but normal strength. Neuromuscular Disorders 2008, 18:892-893.
3. Ambrósio C.E., Fadel L., Gaiad T.P., Martins D.S., Araujo K.P.C., Zucconi E., Brolio M.P., Giglio R.F., Morini A.C., Jazedje T., Froes T.R., Feitosa M.L.T., Valadares M.C., Beltrão-Braga P.C.B., Meirelles F.V., Miglino M.A. Identification of three distinguishable phenotypes in Golden Retriever muscular dystrophy. Genetics and Molecular Research 2009, 8:389-396.
4. Bach J.R. Guide of exams and treatment of neuromuscular diseases. São Paulo: Livraria Santos 2004, 5-14:61.
5. Banks G.B., Chamberlain J.S. The value of mammalian models for duchenne muscular dystrophy in developing therapeutic strategies. Current Topics in Developmental Biology 2008, 431-453. Academic Press, Burlington. R.S. Krauss (Ed.).
6. Barthélémy I., Barrey E., Thibaud J.L., Uriarte A., Voit T., Blot S., Hogrel J.Y. Gait analysis using accelerometry in dystrophin-deficient dogs. Neuromuscular Disorders 2009, 19:788-796.
7. Chakkalakal J.V., Thompson J., Parks R.J., Jasmin B.J. Molecular, cellular and pharmacological therapies for Duchenne/Becker muscular dystorphies. FASEB Journal 2005, 19:880-891.
8. Collins C.A., Morgan J.E. Duchennés muscular dystrophy: animal model used to investigate pathogenesis and develop therapeutic strategies. International Journal of Experimental Pathology 2003, 84:165-172.
9. Corfield G.S., Read R.A., Eastley K.A., Richardson J.L., Robertson I.D., Day R. Assessment of the hip reduction angle for predicting osteoarthritis of the hip in the Labrador retriever. Australian Veterinary Journal 2007, 85:212-216.
10. Honeyman K., Carville K.S., Howell J.M., Fletcher S., Wilton S.D. Development of a snapback method of single-strand conformation polymorphism analysis for genotyping Golden Retrievers for the X-linked muscular dystrophy allele. American Journal of Veterinary Research 1999, 60:734-737.
11. Howell J.M., Fletcher S., Kakulas B.A., O'Hara M., Lochmuller H., Karpati G. Use of the dog model for Duchenne muscular dystrophy in gene therapy trials. Neuromuscular Disorder 1997, 7:325-328.
12. Jaegger G., Marcellin-Little D.J., Levine D. Reliability of goniometry in Labrador Retrievers. American Journal of Veterinary Research 2002, 63:979-986.
13. Kerkis I., Ambrosio C.E., Kerkis A., Martins D.S., Zucconi E., Fonseca S.A.S., Cabral R.M., Maranduba C.M.C., Gaiad T.P., Morini A.C., Vieira N.M., Brolio M.P., Sant'Anna O.A., Miglino M.A., Zatz M. Early transplantation of human immature dental pulp stem cells from baby teeth to Golden Retriever muscular dystrophy (GRMD) dogs: local or systemic?. Journal of Translational Medicine 2008, 6:35.
14. Kornegay J.N., Cundiff D.D., Bogan D.J., Bogan J.R., Okamura C.S. The cranial sartorius muscle undergoes true hypertrophy in dogs with Golden Retriever muscle dystrophy. Neuromuscular Disorders 2003, 13:493-500.
15. Lee D., Stakebake E., Walter R., Carrier D. Effects of mass distribution on the mechanics of level trotting in dogs. The Journal of Experimental Biology 2004, 207:1715-1728.
16. Monk M.L., Preston C.A., McGowan C.M. Effects of early intensive postoperative physiotherapy on limb function after tibial plateau leveling osteotomy in dogs with deficiency of the cranial cruciate ligament. American Journal of Veterinary Research 2006, 67:529-536.
17. Nicholson H.L., Osmotherly P.G., Smith B.A., McGowan C.M. Determinants of passive hip range of motion in adult Greyhounds. Australian Veterinary Journal 2007, 85:217-221.
18. Rovesti G.L., Margini A., Cappellari F., Peirone B. Clinical application of intraoperative skeletal traction in the dog. Veterinary and Comparative Orthopaedics and Traumatology 2006, 19:14-19.
19. Salimena M.C., Lagrota-Candido J., Quírico-Santos T. Gender dimorphism influences extracellular matrix expression and regeneration of muscular tissue in mdx dystrophic mice. Histochemistry and Cell Biology 2004, 122:435-444.
20. Schatzberg S.J., Shelton G.D. New identified of neuromuscular disorders. Veterinary Clinics of North America: Small Animal Practice 2004, 34:1497-1524.
21. Scott E., Mawson S.J. Measurement in Duchenne muscular dystrophy: considerations in the development of a neuromuscular assessment tool. Developmental Medicine and Child Neurology 2006, 48:540-544.
22. Strober J.B. Therapeutics in Duchenne muscular dystrophy. NeuroRX 2006, 3:225-234.
23. Tegeler C.J., Grange R.W., Bogan D.J., Markert C.D., Case D., Kornegay J.N., Childers M.K. Eccentric contractions induce rapid isometric torque drop in dystrophin-deficient dogs. Muscle Nerve 2010, 42:130-132.
24. Thibaud J.L., Monnet A., Bertoldi D., Barthélémy I., Blot S., Carlier P.G. Characterization of dystrophic muscle in Golden Retriever muscular dystrophy dogs by nuclear magnetic resonance imaging. Neuromuscular Disorders 2007, 17:575-584.
25. Vainzof M., Ayub-Guerrieri D., Onofre P.C., Martins P.C., Lopes V.F., Zilberztajn D., Maia L.S., Sell K., Yamamoto L.A. Animal models for genetic neuromuscular diseases. Journal of Molecular Neuroscience 2008, 34:241-248.
26. Valentine B.A., Cooper B.J., de Lahunta A., O'Quinn R., Blue J.T. Canine X-linked muscular dystrophy an animal model of Duchenne muscular dystrophy: clinical studies. Journal of the Neurological Sciences 1988, 88:69-81.
27. Walmsley G.L., Arechavala-Gomeza V., Fernandez-Fuente M., Burke M.M., Nagel N., Holder A., Stanley R., Chandler K., Marks S.L., Muntoni F., Shelton G.D., Piercy R.J. A duchenne muscular dystrophy gene hot spot mutation in dystrophin-deficient cavalier king charles spaniels is amenable to exon 51 skipping. PLoS One 2010, 5:e8647.
28. Willmann R., Possekel S., Dubach-Powell J., Meier T., Ruegg M.A. Mammalian animal models for Duchenne muscular dystrophy. Neuromuscular Disorders 2009, 19:241-249.